• This topic is empty.
Viewing 0 reply threads
  • Author
    Posts
    • #18972

      According to a German working group, trials testing new immunotherapies for MS should focus more on patients’ experiences and symptoms relevant to them. Find out why here.

      What do you think? Do you agree with the German working group?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account